SPEAKERS
IOA
Prof Ismail HD
Indonesia
- Medical Doctor, Faculty of Medicine Universitas Airlangga (1994)
- Orthopaedic Surgeon, Orthopaedic and Traumatology Residency Programme, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital (2003)
- Doctoral Programme (PhD) in Medical Science, Faculty of Medicine, Universitas Indonesia (2004-2005)
- PhD exchange student di National University of Singapore (2006)
- Doctoral Programme (PhD) in Medical Science, with dissertation entitled “Bone Marrow Stromal Stem Cells (bMSCs) Transplantation on Rabbit Model of Intervertebral Disc and Intervertebral Disc Distraction In Reversing Intervertebral Disc Degeneration Into Regenerative Course” (2007)
- Consultant in Hip and Knee Adult Reconstruction, The Indonesian College of Orthopaedic and Traumatology (2012)
- Distinguished Professor Department of Orthopaedic and Traumatology, Cipto Mangunkusumo Hospital-Faculty of Medicine, Universitas Indonesia (2019)
- Head of Stem Cells Integrated Medical Service Unit, Cipto Mangunkusumo Hospital, since 2013.
- Head of Stem Cells and Tissue Engineering Research Center IMERI FKUI since 2016
- Head of Hip and Knee Adult Reconstruction Subscpecialty Program home based FKUI-RSCM
- Head of Stem Cell and Tissue Engineering Committee, Ministry of Health Republic of Indonesia 2016-2020
- Head of Research Task Force, Research Body of The Indonesian Doctor Association since 2019
- Head of Indonesian Stem Cell Association (ASPI), 2016-2019
- Head of Scientific Board, Indonesian Stem Cell Association, 2019-2022
- Chairman of AO Trauma Indonesia 2018-2024
- President, Indonesian Orthopaedic Association, 2022-2025
- Vice Chairman Asean Orthopaedic Research Society (AORS) since 2022
- Chairman Asia Pacific Orthopaedic Research Society (APORS) 2023 – 2025
- Published 125 publications, consist of 90 international publication (43 PubMed indexed dan 52 Scopus Indexed) and 35 national publication and holds 6 patent (periarticular external fixation, modified C-clamp, spine distractor dan spine compactor, scaffold composite from amorf and alginate hydroxyapatite, dan Culutre method and use of MSC on fibrin sheet for open wound).
- Received 27 national dan international award
- Research topic and Clinical Application in Orthopaedic and Traumatology, specifically trauma, pelvic acetabulum surgery, hip and knee adult reconstruction dan stem cell application for Orthopaedic cases.
Fellowship
1.Lee Shaw Foundation Orthopaedic Fellowship, attached in division of adult reconstruction-sport medicine, Department Of Orthopaedic Surgery, National University Hospital, Singapore, under supervision Prof. Shamal Das De and Prof VP Kumar, 26 April-25 September 2004
2.Junior AO East Asia (AOEA) fellowship at Bangkok, Royal Airforce Hospital, under supervision of Dr. Vajara Phiphobmongkol, October 2-13, 2005
3.AO fellowship in Regions hospitals, St. Paul, Minnesota, USA, under supervision of Prof. Peter Cole, October 25-November 24, 2007
4.ASEAN-American Orthopaedic Association Travelling Fellowship, USA, May 23- June 12, 2010
5.Trauma Fellowship in Hannover Medical School under supervision Prof. Christian Krettek on May 27 – June 1, 2012
6.Clinical attachment on pelvic and acetabulum surgery, clinical and operative orthopaedic surgery, harborview medical center , Department of Orthopaedic Surgery in Seattle, Washington state, USA, under supervision of Mr. Milton Chip Routt, Prof., February 13-17, 2012
7.Arthroplasty short fellowship in Chang Gang Memorial Hospital, Taipei, under supervision Prof. Mel S Lee, on 1-11 April 2013.
8.Observership in New York University Hospitals Center Department of Orthopaedic Surgery, New York under supervision Prof. Richard Iorio, on 6-10 May 2013.
9.Observership in Massachusetts General Hospital Departement of Orthopedic Surgery, under supervision of Prof. Harry Rubash, 28 September-9 October 2015
10.AO visit expert fellowship and Observership in Hermann Memorial Hospital, University of Texas, Houston, under supervision of Mr. Milton Chip Routt, Prof., 6-17 March 2016
CURRENT RESEARCH PROJECT
- Extracellular Vesicles (EVs) from Induced COVID-19 Patients serum iPSCs as Regenerative Immunotherapy for Severe and Critical COVID-19 Patients
- Umbilical-cord Mesenchymal Stem Cells for Critical COVID-19 Pneumonia
- Umbilical-cord Mesenchymal Stem Cells for Moderate-Severe COVID-19 Pneumonia
- Allogenic mesenchymal stem cells for bone and joint restore, repair, regenerate and replace
- Allogenic mesenchymal stem cells for non-union and critical size bone defect of the long bone fracture
- Umbilical cord derived mesenchymal stem cells for osteoarthritis of the knee
- Pelvic and acetabular surgery project
- Primary difficult total hip replacement
- Role of cage and ring in acetabular revision surgery